Overview

Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of autologous tumor lysate-pulsed dendritic and cytokine-induced killer cells (DC-CIK) for colorectal cancer (CRC).
Phase:
Phase 2
Details
Lead Sponsor:
Shenzhen Hornetcorn Bio-technology Company, LTD
Collaborator:
Jingzhou Central Hospital